Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Intrauterine Exposure to Carbamazepine and Specific Congenital Malformations: Systematic Review and Case-Control Study
BMJ 341:c6581, 1229, Jentik,J.,et al, 2010
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
Malformation Risks of Antiepileptic Drugs in Pregnancy: A Prospective Study from the UK Epilepsy and Pregnancy Register
JNNP 77:193-198,145, Morrow,J.,et al, 2006
Teratogenicity of Antiepileptic Drugs
BMJ 333:615-616, Breen,D.P. &Davenport,R.J., 2006
The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001
Is Carbamazepine Teratogenic? A Prospective Controlled Study of 210 Pregnancies
Neurol 57:321-324, Diav-Citrin,O.,et al, 2001
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993
New Uses and Old for Carbamazepine
Patient Care 24:48-81, Browne,T.R.,et al, 1990
Sodium Valproate
Editorial, Lancet 2:1229-12311988., , 1988